Package 0536-1333-36

{"route": ["ORAL"], "spl_id": "4f4c9058-ec1c-48d5-81df-56188b7ae803", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["495W7451VQ", "6V9V2RYJ8N"], "rxcui": ["1305603"], "spl_set_id": ["997946e6-eff0-4c15-8694-020a19c2d336"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["RUGBY LABORATORIES, INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 CARTON (0536-1333-21)  / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "0536-1333-21", "marketing_start_date": "20220404"}, {"sample": false, "description": "2 BLISTER PACK in 1 CARTON (0536-1333-36)  / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "0536-1333-36", "marketing_start_date": "20220404"}], "brand_name": "Guaifenesin D", "product_id": "0536-1333_4f4c9058-ec1c-48d5-81df-56188b7ae803", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "0536-1333", "generic_name": "Guaifenesin and Pseudoephedrine Hydrochloride", "labeler_name": "RUGBY LABORATORIES, INC.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Guaifenesin D", "active_ingredients": [{"name": "GUAIFENESIN", "strength": "600 mg/1"}, {"name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "strength": "60 mg/1"}], "application_number": "ANDA212542", "marketing_category": "ANDA", "marketing_start_date": "20220404", "listing_expiration_date": "20261231"}